Qingyuan Zhang

机构：Harbin Medical University · ORCID：0000-0001-7618-4393

发表论文 215 篇 · 总被引 5801 次 · h-index 41

代表论文

• Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer (2025 · New England Journal of Medicine · 被引 55)
• Trastuzumab deruxtecan (T-DXd) + pertuzumab (P) vs taxane + trastuzumab + pertuzumab (THP) for first-line (1L) treatment of patients (pts) with human epidermal growth factor receptor 2–positive (HER2+) advanced/metastatic breast cancer (a/mBC): Interim results from DESTINY-Breast09. (2025 · Journal of Clinical Oncology · 被引 31)
• Preoperative prediction of lymph node metastasis in patients with ovarian cancer using contrast-enhanced computed tomography-based intratumoral and peritumoral radiomics features (2025 · Frontiers in Oncology · 被引 3)
• Telpegfilgrastim for chemotherapy-induced neutropenia in patients with non-small cell lung cancer: a multicentre, randomized, phase 3 study (2025 · BMC Cancer · 被引 3)
• Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial (2025 · Signal Transduction and Targeted Therapy · 被引 2)
• PVA/CS-based multifunctional hydrogel strain/gas flexible sensor for health monitoring (2025 · Chemical Engineering Journal · 被引 2)